Nanoparticles Show Promise for Treating Intestinal Inflammation, Biomedical Research Study Finds

ATLANTA—Nanoparticles designed to block a cell-surface molecule that plays a key role in inflammation could be a safe treatment for inflammatory bowel disease (IBD), according to researchers in the Institute for Biomedical Sciences at Georgia State University and Southwest University in China.

The scientists developed nanoparticles, or microscopic particles, to reduce the expression of… more »

Leading Virologist Chris Basler Named Founding Director of Center for Microbial Pathogenesis

ATLANTA—Dr. Chris Basler, a world-renowned research leader in the study of emerging viruses, including the Ebola virus, has been named founding director of the Center for Microbial Pathogenesis, Institute for Biomedical Sciences (IBMS), at Georgia State University.

Recruited from Icahn School of Medicine at Mount Sinai in New York, Basler joins Georgia State… more »

Cytokine Plays Dual Role in Regulating Inflammatory Bowel Disease, Biomedical Research Study Finds

ATLANTA—Small proteins that affect communication between cells play an important role in regulating inflammation that occurs during inflammatory bowel disease, according to researchers at Georgia State University, Emory University, the University of Michigan and Amgen, a biotechnology company.

The researchers compared immune cells in mice with and without intestinal inflammation and identified a new… more »